RVNC earnings call for the period ending September 30, 2021.
Compare RVNC Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Revance Therapeutics
A surprise rejection is weighing on the biopharma's shares today.
Management's response to a publicly disclosed regulatory form has investors doing a U-turn.
RVNC earnings call for the period ending March 31, 2020.
RVNC earnings call for the period ending December 31, 2019.
The company's frown line treatment moved closer to commercialization today.
A new deal accelerates the company's shift to a commercial-stage biotech.
Several companies raised capital on Wednesday.
The pricing of a secondary offering is to blame.
RVNC earnings call for the period ending September 30, 2019.